HIT Consultant May 21, 2024
Fred Pennic

What You Should Know:

WearLinq, a leader in wearable health monitoring, announced a strategic acquisition of AMI Cardiac Monitoring, LLC, a seasoned player in ambulatory cardiac monitoring.

– The acquisition, coupled with a recent $6.7M funding round, positions WearLinq to significantly expand access to their innovative eWave 6-lead ECG monitor and revolutionize the fight against atrial fibrillation (AFib), which recently received FDA 510(k) clearance.

Tackling the Silent Threat of AFib

AFib, a heart rhythm irregularity, affects one in three people in their lifetime. It increases stroke risk fivefold and often leads to heart failure. Yet, current diagnostic methods miss a significant portion of cases, with over 30% of patients receiving false negatives and needing retesting within...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Mergers & Acquisitions / JV, Technology, Trends, Wearables
Apple study will look at the role tech can play in health
AI-enabled wearable sensor uses vibration to curb nocturnal scratching
Wearable Tech Is Changing Fitness—Here's How Studios Can Keep Up
Apple taps Brighman and Women's Hospital for early disease detection
ŌURA Secures $200 Million in Series D Funding

Share This Article